The end of the beginning: oncolytic virotherapy achieves clinical proof-of-concept

Mol Ther. 2006 Feb;13(2):237-8. doi: 10.1016/j.ymthe.2005.12.005. Epub 2005 Dec 20.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adenoviridae / genetics
  • Adenoviruses, Human / genetics*
  • Antineoplastic Agents / administration & dosage*
  • Clinical Trials, Phase III as Topic / trends
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / therapy*
  • Head and Neck Neoplasms / virology
  • Humans
  • Nasopharyngeal Neoplasms / drug therapy
  • Nasopharyngeal Neoplasms / therapy*
  • Nasopharyngeal Neoplasms / virology
  • Oncolytic Virotherapy* / trends
  • Oncolytic Viruses / genetics*
  • Viral Vaccines

Substances

  • Antineoplastic Agents
  • Viral Vaccines
  • dl1520